Edward J Cain

Array ( [id] => 8720225 [patent_doc_number] => 20130071442 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-21 [patent_title] => 'Aerosolized Fosfomycin/Aminoglycoside Combination for the Treatment of Bacterial Respiratory Infections' [patent_app_type] => utility [patent_app_number] => 13/616544 [patent_app_country] => US [patent_app_date] => 2012-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 11908 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13616544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10405705 [patent_doc_number] => 20150290713 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-15 [patent_title] => 'Methods for Producing Platelet Materials' [patent_app_type] => utility [patent_app_number] => 14/427924 [patent_app_country] => US [patent_app_date] => 2012-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11868 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14427924 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8904903 [patent_doc_number] => 20130172406 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-04 [patent_title] => 'Cancer Cell Targeting Using Nanoparticles' [patent_app_type] => utility [patent_app_number] => 13/595592 [patent_app_country] => US [patent_app_date] => 2012-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 30691 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13595592 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8659165 [patent_doc_number] => 20130039994 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-14 [patent_title] => 'LOW DOSE COLONIC CLEANSING SYSTEM' [patent_app_type] => utility [patent_app_number] => 13/589859 [patent_app_country] => US [patent_app_date] => 2012-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3655 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13589859 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8586979 [patent_doc_number] => 20130005800 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-03 [patent_title] => 'COMPOSITION FOR TRANSDERMAL OR TRANSMUCOSAL ADMINISTRATION' [patent_app_type] => utility [patent_app_number] => 13/572987 [patent_app_country] => US [patent_app_date] => 2012-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6323 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13572987 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9772593 [patent_doc_number] => 20140296257 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-02 [patent_title] => 'High-Loading Water-Soluable Carrier-Linked Prodrugs' [patent_app_type] => utility [patent_app_number] => 14/237429 [patent_app_country] => US [patent_app_date] => 2012-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35888 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14237429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8476772 [patent_doc_number] => 20120276179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-01 [patent_title] => 'COSMETIC PRODUCT, NANOPARTICLES FOR COSMETICS, AND POWDER FOR COSMETICS' [patent_app_type] => utility [patent_app_number] => 13/537643 [patent_app_country] => US [patent_app_date] => 2012-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7170 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13537643 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8416700 [patent_doc_number] => 20120244200 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-27 [patent_title] => 'METHOD FOR INCORPORATING A HYDROPHOBIC MATERIAL INTO A SKIN CARE COMPOSITION' [patent_app_type] => utility [patent_app_number] => 13/488952 [patent_app_country] => US [patent_app_date] => 2012-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 4977 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13488952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8495496 [patent_doc_number] => 20120294904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-22 [patent_title] => 'POLYSIALIC ACID-BASED N-TRIMETHYL CHITOSAN GEL NANOPARTICLES FOR SYSTEMIC DRUG DELIVERY' [patent_app_type] => utility [patent_app_number] => 13/474749 [patent_app_country] => US [patent_app_date] => 2012-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 5168 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13474749 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8515928 [patent_doc_number] => 20120315336 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-13 [patent_title] => 'INJECTABLE NANOPARTICULATE OLANZAPINE FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 13/463564 [patent_app_country] => US [patent_app_date] => 2012-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11937 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13463564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8495495 [patent_doc_number] => 20120294903 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-22 [patent_title] => 'METHODS AND SYSTEMS OF MAKING NANOSTRUCTURES' [patent_app_type] => utility [patent_app_number] => 13/457609 [patent_app_country] => US [patent_app_date] => 2012-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10271 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13457609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8335166 [patent_doc_number] => 20120201867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'DRUG DELIVERY FROM EMBOLIC AGENTS' [patent_app_type] => utility [patent_app_number] => 13/452493 [patent_app_country] => US [patent_app_date] => 2012-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9107 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13452493 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17133640 [patent_doc_number] => 11135174 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-10-05 [patent_title] => Coated mesoporous nanoparticles [patent_app_type] => utility [patent_app_number] => 14/110839 [patent_app_country] => US [patent_app_date] => 2012-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 8241 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 232 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14110839 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8617370 [patent_doc_number] => 20130022682 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-24 [patent_title] => 'Ultra-Stable Oligonucleotide-Gold And-Silver Nanoparticle Conjugates And Method Of Their Preparation' [patent_app_type] => utility [patent_app_number] => 13/437940 [patent_app_country] => US [patent_app_date] => 2012-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 6790 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13437940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8251934 [patent_doc_number] => 20120156257 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-21 [patent_title] => 'METHOD FOR THE PREPARATION OF NANOPARTICLES' [patent_app_type] => utility [patent_app_number] => 13/329999 [patent_app_country] => US [patent_app_date] => 2011-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6691 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20120156257.pdf [firstpage_image] =>[orig_patent_app_number] => 13329999 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8138815 [patent_doc_number] => 20120093948 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'Nitric Oxide Treatments' [patent_app_type] => utility [patent_app_number] => 13/310359 [patent_app_country] => US [patent_app_date] => 2011-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 31502 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20120093948.pdf [firstpage_image] =>[orig_patent_app_number] => 13310359 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8824865 [patent_doc_number] => 20130125910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-23 [patent_title] => 'Use of Electrophoretic Microcapsules in a Cosmetic Composition' [patent_app_type] => utility [patent_app_number] => 13/299745 [patent_app_country] => US [patent_app_date] => 2011-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12264 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13299745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7808116 [patent_doc_number] => 20120059070 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-08 [patent_title] => 'POWDEROUS FORMULATIONS OF FAT-SOLUBLE ACTIVE INGREDIENTS' [patent_app_type] => utility [patent_app_number] => 13/294676 [patent_app_country] => US [patent_app_date] => 2011-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1615 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20120059070.pdf [firstpage_image] =>[orig_patent_app_number] => 13294676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9033915 [patent_doc_number] => 20130236553 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-12 [patent_title] => 'Compositions and Methods for the Delivery of Therapeutics' [patent_app_type] => utility [patent_app_number] => 13/880819 [patent_app_country] => US [patent_app_date] => 2011-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 24508 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13880819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8476744 [patent_doc_number] => 20120276151 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-01 [patent_title] => 'DRUG DELIVERY FROM EMBOLIC AGENTS' [patent_app_type] => utility [patent_app_number] => 13/282953 [patent_app_country] => US [patent_app_date] => 2011-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9043 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13282953 [rel_patent_id] =>[rel_patent_doc_number] =>)